Cargando…
Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
Tumor angiogenesis plays an important role in the progression and metastasis of ovarian cancer. EGFL6 protein is highly expressed in ovarian cancer and has been proposed to play an important role in promoting tumor angiogenesis. Here, a CRISPR/Cas9 system was used to knockout the EGFL6 gene in the o...
Autores principales: | Zhu, Wenhui, Liu, Chunyan, Lu, Tongyi, Zhang, Yinmei, Zhang, Simin, Chen, Qi, Deng, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477343/ https://www.ncbi.nlm.nih.gov/pubmed/32983976 http://dx.doi.org/10.3389/fonc.2020.01451 |
Ejemplares similares
-
CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020) -
miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis
por: Wu, Binhua, et al.
Publicado: (2020) -
The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020) -
Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
por: Lu, Tongyi, et al.
Publicado: (2018) -
Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Publicado: (2021)